← Back to Search

Behavioural Intervention

NeuroGlove for PTSD

N/A

Waitlist Available

Led By Eric Nussbaum, MD

Research Sponsored by NeuroGlove LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Carry an active diagnosis of PTSD.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks

Awards & highlights

Study Summary

This trial studies a new technology to treat PTSD in 6 people. It's called the NeuroGlove.

Who is the study for?

This trial is for men and women aged 18 to 85 who have been diagnosed with PTSD and experience symptoms that affect their daily life. Participants must be able to give informed consent themselves, without a legal representative.Check my eligibility

What is being tested?

The NeuroGlove study is testing a home-based treatment on six individuals with PTSD. The aim is to see how effective the NeuroGlove device is in managing the condition.See study design

What are the potential side effects?

Since this summary does not provide specific side effects of using the NeuroGlove, it's important for participants to ask about potential risks or discomforts associated with its use during the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with PTSD.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PTSD Symptom Reduction

Portion of participants with adverse events

Secondary outcome measures

PTSD Symptom Severity

Trial Design

1Treatment groups

Experimental Treatment

Group I: NeuroGlove Treatment ArmExperimental Treatment1 Intervention

Study participants undergoing treatment using the NeuroGlove.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

NeuroGlove LLCLead Sponsor

2 Previous Clinical Trials

23 Total Patients Enrolled

Eric Nussbaum, MDPrincipal InvestigatorNeuroGlove LLC

1 Previous Clinical Trials

10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study accept participants who are in their late seventies?

"This study is actively seeking participants who are of age and not above 85 years old."

Answered by AI

Who meets the requirements to join this clinical trial?

"This research is enrolling 6 individuals aged 18 to 85 who are coping with post-traumatic stress disorder. Prerequisites for enrolment include regular PTSD symptoms that impede a patient's daily routine and overall well being."

Answered by AI

Can people currently enroll in this experiment?

"Per the clinicaltrials.gov listing, this medical trial is no longer recruiting patients. Initially posted on August 14th 2023 and last updated on September 21st 2023, it has since been superseded by 408 other active trials currently enrolling participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

NeuroGlove PTSD Study

2023. "NeuroGlove PTSD Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06050590.